Millennium Management LLC Acquires 86,000 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Millennium Management LLC increased its holdings in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 565.1% in the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 101,218 shares of the company’s stock after purchasing an additional 86,000 shares during the quarter. Millennium Management LLC owned 0.20% of Prestige Consumer Healthcare worth $6,969,000 as of its most recent filing with the SEC.

A number of other large investors have also bought and sold shares of PBH. Congress Asset Management Co. MA boosted its holdings in shares of Prestige Consumer Healthcare by 596.2% in the 4th quarter. Congress Asset Management Co. MA now owns 679,256 shares of the company’s stock valued at $41,584,000 after buying an additional 581,685 shares during the last quarter. Ariel Investments LLC lifted its holdings in Prestige Consumer Healthcare by 10.7% during the 2nd quarter. Ariel Investments LLC now owns 2,835,203 shares of the company’s stock valued at $195,204,000 after purchasing an additional 274,212 shares during the last quarter. Allspring Global Investments Holdings LLC lifted its holdings in Prestige Consumer Healthcare by 26.0% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 1,320,125 shares of the company’s stock valued at $90,891,000 after purchasing an additional 272,773 shares during the last quarter. Victory Capital Management Inc. lifted its holdings in Prestige Consumer Healthcare by 9.0% during the 2nd quarter. Victory Capital Management Inc. now owns 2,074,460 shares of the company’s stock valued at $142,827,000 after purchasing an additional 171,357 shares during the last quarter. Finally, F M Investments LLC acquired a new stake in Prestige Consumer Healthcare during the 2nd quarter valued at $11,162,000. 99.95% of the stock is owned by institutional investors.

Prestige Consumer Healthcare Stock Performance

Prestige Consumer Healthcare stock opened at $68.41 on Friday. Prestige Consumer Healthcare Inc. has a 12-month low of $56.61 and a 12-month high of $75.80. The company has a quick ratio of 1.90, a current ratio of 3.23 and a debt-to-equity ratio of 0.65. The business’s 50-day moving average price is $70.93 and its two-hundred day moving average price is $69.33. The stock has a market cap of $3.40 billion, a PE ratio of 16.41, a P/E/G ratio of 1.98 and a beta of 0.47.

Prestige Consumer Healthcare (NYSE:PBH) last released its quarterly earnings results on Thursday, August 8th. The company reported $0.90 earnings per share for the quarter, topping the consensus estimate of $0.86 by $0.04. The company had revenue of $267.10 million for the quarter, compared to analysts’ expectations of $260.54 million. Prestige Consumer Healthcare had a return on equity of 12.55% and a net margin of 18.43%. The business’s quarterly revenue was down 4.4% compared to the same quarter last year. During the same period in the previous year, the business posted $1.06 earnings per share. As a group, analysts expect that Prestige Consumer Healthcare Inc. will post 4.43 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on PBH. Jefferies Financial Group reissued a “hold” rating and set a $76.00 target price (up previously from $70.00) on shares of Prestige Consumer Healthcare in a report on Tuesday, September 24th. DA Davidson raised their price target on Prestige Consumer Healthcare from $93.00 to $95.00 and gave the stock a “buy” rating in a research report on Wednesday, August 28th. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $94.20.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.